Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reggiani

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771AM Quartaroli, C Carignani, G Dal Forno, et al.
Archiv Der Pharmazie|May 6, 1999
Cycloalkyl indole-2-carboxylates as useful tools for mapping the "north-eastern" region of the glycine binding site associated with the NMDA receptorF Micheli, R Di Fabio, A M Capelli, et al.
Tumori|July 1, 1996
A new regimen of cisplatin, epirubicin and methotrexate (PEM-3) as primary chemotherapy for locally advanced bladder cancerN Cacciari, A Martoni, A P Rossi, et al.
Journal of Medicinal Chemistry|March 14, 1997
Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding siteR Di Fabio, A M Capelli, N Conti, et al.
Journal of Medicinal Chemistry|October 6, 2000
Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonistsA Ursini, A M Capelli, R A Carr, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771AM Quartaroli, C Carignani, G Dal Forno, et al.
Archiv Der Pharmazie|May 6, 1999
Cycloalkyl indole-2-carboxylates as useful tools for mapping the "north-eastern" region of the glycine binding site associated with the NMDA receptorF Micheli, R Di Fabio, A M Capelli, et al.
Tumori|July 1, 1996
A new regimen of cisplatin, epirubicin and methotrexate (PEM-3) as primary chemotherapy for locally advanced bladder cancerN Cacciari, A Martoni, A P Rossi, et al.
Journal of Medicinal Chemistry|March 14, 1997
Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding siteR Di Fabio, A M Capelli, N Conti, et al.
Journal of Medicinal Chemistry|October 6, 2000
Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonistsA Ursini, A M Capelli, R A Carr, et al.
Pageof 11